TNSN95062A1 - Nouveaux derives dialkoxy-pyridinyle-benzimidazole - Google Patents
Nouveaux derives dialkoxy-pyridinyle-benzimidazoleInfo
- Publication number
- TNSN95062A1 TNSN95062A1 TNTNSN95062A TNSN95062A TNSN95062A1 TN SN95062 A1 TNSN95062 A1 TN SN95062A1 TN TNSN95062 A TNTNSN95062 A TN TNSN95062A TN SN95062 A TNSN95062 A TN SN95062A TN SN95062 A1 TNSN95062 A1 TN SN95062A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compounds
- methyl
- pyridinyle
- dialkoxy
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9400511 | 1994-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN95062A1 true TNSN95062A1 (fr) | 1996-02-06 |
Family
ID=20392945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN95062A TNSN95062A1 (fr) | 1994-05-27 | 1994-05-29 | Nouveaux derives dialkoxy-pyridinyle-benzimidazole |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0712401A1 (is) |
| JP (1) | JPH09504557A (is) |
| CN (1) | CN1128997A (is) |
| AU (1) | AU2633095A (is) |
| BR (1) | BR9506235A (is) |
| CA (1) | CA2166988A1 (is) |
| CZ (1) | CZ24396A3 (is) |
| EE (1) | EE9600011A (is) |
| FI (1) | FI960367A0 (is) |
| HU (1) | HU9600005D0 (is) |
| IL (1) | IL113604A0 (is) |
| IS (1) | IS4321A (is) |
| MA (1) | MA23563A1 (is) |
| NO (1) | NO960268D0 (is) |
| PL (1) | PL312692A1 (is) |
| TN (1) | TNSN95062A1 (is) |
| WO (1) | WO1995032959A1 (is) |
| ZA (1) | ZA954125B (is) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
| GB9423968D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| BR9915421A (pt) * | 1998-11-18 | 2001-08-07 | Astrazeneca Ab | Processo para a fabricação de sais alcalinos levemente solúveis ou menos solúveis de heterociclos de sulfinila substituìda, forma de dosagem farmacêutica, uso da mesma, método de tratamento de doenças gastrointestinais, e, processo para a fabricação de uma forma de dosagem farmacêutica. |
| US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| EP2486910A3 (en) | 2006-10-27 | 2012-08-22 | The Curators Of The University Of Missouri | Multi-chambered apparatus comprising a dispenser head |
| US8247440B2 (en) | 2008-02-20 | 2012-08-21 | Curators Of The University Of Missouri | Composition comprising omeprazole, lansoprazole and at least one buffering agent |
| BRPI0918492A2 (pt) | 2008-09-09 | 2015-12-01 | Astrazeneca Ab | uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo |
| SG176724A1 (en) | 2009-06-25 | 2012-01-30 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
| US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3049367B2 (ja) * | 1990-06-20 | 2000-06-05 | アストラゼネカ・アクチエボラーグ | ジアルコキシ−ピリジニル−ベンズイミダゾール誘導体、その製造方法およびそれを含む医薬 |
| DE4035455A1 (de) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
-
1994
- 1994-05-29 TN TNTNSN95062A patent/TNSN95062A1/fr unknown
-
1995
- 1995-05-03 IL IL11360495A patent/IL113604A0/xx unknown
- 1995-05-11 WO PCT/SE1995/000519 patent/WO1995032959A1/en not_active Application Discontinuation
- 1995-05-11 CA CA002166988A patent/CA2166988A1/en not_active Abandoned
- 1995-05-11 AU AU26330/95A patent/AU2633095A/en not_active Abandoned
- 1995-05-11 PL PL95312692A patent/PL312692A1/xx unknown
- 1995-05-11 JP JP8500730A patent/JPH09504557A/ja active Pending
- 1995-05-11 HU HU9600005A patent/HU9600005D0/hu unknown
- 1995-05-11 CZ CZ96243A patent/CZ24396A3/cs unknown
- 1995-05-11 CN CN95190482A patent/CN1128997A/zh active Pending
- 1995-05-11 EE EE9600011A patent/EE9600011A/xx unknown
- 1995-05-11 BR BR9506235A patent/BR9506235A/pt not_active Application Discontinuation
- 1995-05-11 EP EP95921187A patent/EP0712401A1/en not_active Withdrawn
- 1995-05-19 ZA ZA954125A patent/ZA954125B/xx unknown
- 1995-05-26 MA MA23901A patent/MA23563A1/fr unknown
-
1996
- 1996-01-17 IS IS4321A patent/IS4321A/is unknown
- 1996-01-23 NO NO960268A patent/NO960268D0/no unknown
- 1996-01-26 FI FI960367A patent/FI960367A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH09504557A (ja) | 1997-05-06 |
| AU2633095A (en) | 1995-12-21 |
| ZA954125B (en) | 1995-11-27 |
| MA23563A1 (fr) | 1995-12-31 |
| FI960367A (fi) | 1996-01-26 |
| NO960268L (no) | 1996-01-23 |
| EP0712401A1 (en) | 1996-05-22 |
| IS4321A (is) | 1996-01-17 |
| PL312692A1 (en) | 1996-05-13 |
| NO960268D0 (no) | 1996-01-23 |
| BR9506235A (pt) | 1997-08-12 |
| HU9600005D0 (en) | 1996-03-28 |
| FI960367A0 (fi) | 1996-01-26 |
| WO1995032959A1 (en) | 1995-12-07 |
| EE9600011A (et) | 1996-04-15 |
| CN1128997A (zh) | 1996-08-14 |
| CZ24396A3 (en) | 1996-06-12 |
| IL113604A0 (en) | 1995-08-31 |
| CA2166988A1 (en) | 1995-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN95062A1 (fr) | Nouveaux derives dialkoxy-pyridinyle-benzimidazole | |
| FR2421889A1 (fr) | Nouveaux derives d'acide thiazolidinecarboxylique-4 utiles comme medicaments antihypertenseurs et procedes pour leur preparation | |
| EG17795A (en) | Process for preparing of 3-substituted 2-oxindole-1-carboxaimes as analgese and anti-inflammatory agents | |
| KR930700482A (ko) | 신경보호성 안돌론 및 관련 유도체 | |
| HUP9802937A2 (hu) | Benzo[g]kinolin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
| TNSN91049A1 (fr) | Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique | |
| IL85988A (en) | 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them | |
| FR2438654A1 (fr) | Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose | |
| KR950005823A (ko) | 5-아미노-8-메틸-7-피롤리디닐퀴놀린-3-카르본산유도체 | |
| KR900018027A (ko) | 피페리딘 유도체, 그의 제조 방법, 및 그것을 유효성분으로 함유하는 의약용 조성물 | |
| YU47338B (sh) | Novo jedinjenje 4-fluoro-2-// (4-metoksi-2-piridinil)metil-/sulfinil/- 1h-benzimidazol i postupak za njegovo dobijanje | |
| DE3568440D1 (en) | New (8s)-8-fluoroerythromycin derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them | |
| TNSN95063A1 (fr) | Nouveaux benzimidazoles substitues | |
| FR2440353A1 (fr) | Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament | |
| HUP0004058A2 (hu) | Készítmények és eljárások biológiai membránok permeabilitásának reverzibilis növelésére | |
| KR890009912A (ko) | 퀴놀린 유도체 및 그의 제조법 | |
| FR2603587A1 (fr) | Derives de la 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonine (ou -1,4-benzoxazonine), procede pour leur preparation, medicaments les contenant et composes intermediaires | |
| AU687023B2 (en) | Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development | |
| FR2355839A1 (fr) | Derives optiquement actifs d'acide benzoxazolyl-propionique, procede pour leur preparation et compositions therapeutiques les contenant | |
| ES487631A1 (es) | Procedimiento para la obtencion de hexahidro-1,4-oxazepinas | |
| FR2506767A1 (fr) | Derives heterocycliques d'amidoximes, leur preparation et leur application en therapeutique | |
| ES8703441A1 (es) | Un procedimiento para la preparacion de agentes anti-hiperglicemicos de lactona. | |
| JO1870B1 (en) | CO2 derivatives - pyridinyl benzimidazole innovative | |
| JO1871B1 (en) | Innovative substituted benzimidazole compounds | |
| FR2456724A1 (fr) | Esters de 2-(6-methoxy-2-naphtyl)-1-propanol, leur procede de preparation et leur application en therapeutique |